“…Only five studies were multicentre investigations 23,33,36,38,39 . Most studies were performed in critically ill patients with respiratory failure 15,16,18,22,24,26,27,29–31,33,35,36,39,41,46,47,54,62 ; twelve studies in patients after cardiac surgery 13,17,25,28,34,48–51,57 or general surgery, 20,23,43 four in difficult to wean patients, 19,32,38,40,56 four in COPD patients 14,21,44,45 and four in ARDS patients 37,42,53,55 . Nine studies tested SmartCare, 14,15,18,19,23,32,47,54,63 fourteen studies ASV, 13,17,21,42,43,45,46,48–53,55 eight studies INTELLiVENT–ASV, 22,24,25,27,28,30,34,35 eight studies NAVA, 20,36–41,62 six studies PAV+, 16,26,29,31,33,44 three studies Avea–CLiO 2 58–60 and one closed loop FiO 2 titrations during ASV 61 .…”